company background image
NH

NantHealthNasdaqGS:NH Stock Report

Market Cap

US$129.3m

7D

-12.5%

1Y

-53.7%

Updated

01 Dec, 2021

Data

Company Financials +
NH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health2/6
Dividends0/6

NH Stock Overview

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally.

NantHealth Competitors

Inovalon Holdings

NasdaqGS:INOV

US$6.4b

Change Healthcare

NasdaqGS:CHNG

US$6.3b

Evolent Health

NYSE:EVH

US$2.3b

Health Catalyst

NasdaqGS:HCAT

US$2.3b

Price History & Performance

Summary of all time highs, changes and price drops for NantHealth
Historical stock prices
Current Share PriceUS$1.12
52 Week HighUS$6.60
52 Week LowUS$1.06
Beta1.7
1 Month Change-28.66%
3 Month Change-49.55%
1 Year Change-53.72%
3 Year Change31.78%
5 Year Change-88.71%
Change since IPO-93.98%

Recent News & Updates

Shareholder Returns

NHUS Healthcare ServicesUS Market
7D-12.5%-0.8%-2.8%
1Y-53.7%-9.1%20.0%

Return vs Industry: NH underperformed the US Healthcare Services industry which returned -9.1% over the past year.

Return vs Market: NH underperformed the US Market which returned 20% over the past year.

Price Volatility

Is NH's price volatile compared to industry and market?
NH volatility
NH Average Weekly Movement8.9%
Healthcare Services Industry Average Movement8.3%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: NH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: NH's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010354Patrick Soon-Shionghttps://nanthealth.com

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.

NantHealth Fundamentals Summary

How do NantHealth's earnings and revenue compare to its market cap?
NH fundamental statistics
Market CapUS$129.30m
Earnings (TTM)-US$61.72m
Revenue (TTM)US$65.26m

2.0x

P/S Ratio

-2.1x

P/E Ratio

Valuation

Is NantHealth undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether NantHealth is trading at an attractive price based on the cash flow it is expected to produce in the future. But as NantHealth has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is NantHealth forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

-0.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NH's revenue (16.6% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: NH's revenue (16.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NH's Return on Equity is forecast to be high in 3 years time


Past Performance

How has NantHealth performed over the past 5 years?

15.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NH is currently unprofitable.

Growing Profit Margin: NH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NH is unprofitable, but has reduced losses over the past 5 years at a rate of 15.1% per year.

Accelerating Growth: Unable to compare NH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17%).


Return on Equity

High ROE: NH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is NantHealth's financial position?


Financial Position Analysis

Short Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: NH has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: NH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NH has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NH has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 29% each year.


Dividend

What is NantHealth current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Patrick Soon-Shiong (68 yo)

11.33yrs

Tenure

Dr. Patrick Soon-Shiong, M.D., FRCS (C), FACS, MBBCh, MSc, FRCS (C), is an Owner and Executive Chairman of Los Angeles Times Communications, LLC. Dr. Soon-Shiong serves as a Director at Keyssa, Inc. He ser...


Leadership Team

Experienced Management: NH's management team is considered experienced (2 years average tenure).


Board Members

Experienced Board: NH's board of directors are considered experienced (5.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.


Top Shareholders

Company Information

NantHealth, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: NantHealth, Inc.
  • Ticker: NH
  • Exchange: NasdaqGS
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$129.299m
  • Shares outstanding: 115.45m
  • Website: https://nanthealth.com

Number of Employees


Location

  • NantHealth, Inc.
  • 9920 Jefferson Boulevard
  • Culver City
  • California
  • 90232
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/01 00:10
End of Day Share Price2021/11/30 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.